Depurination, the release of purine bases from nucleic acids by hydrolysis of the N-glycosidic bond, gives rise to alterations of the cell genome. Though cells have evolved mechanisms to repair these lesions, unrepaired apurinic sites have been shown to have two biological consequences: lethality and base substitution errors. 2-Bromopropane (2-BP) is used as an intermediate in the synthesis of pharmaceuticals, dyes, and other organics. In addition, 2-BP has been used as a replacement for chloroflurocarbons and 1,1,1-trichloroethane as a cleaning solvent in electronics industry. However, 2-BP was found to cause reproductive and hematopoietic disorders in local workers exposed to it. Owing to the toxicity of 2-BP, there has been a tendency to use 1-BP as an alternative cleaning solvent to 2-BP. However, 1-BP has also been reported to be neurotoxic in rats. Though N 7 -guanine adduct of 2-BP has been reported previously, massive depurination of the nucleosides and calf thymus DNA was observed in this study. We incubated the nucleosides (ddG, dG, guanosine, ddA, dA and adenosine) with excess amount 2-BP at the physiological condition (pH 7.4, 37 o C), which were analyzed by HPLC and LC-MS/MS. In addition, the time and dose response relationship of depurination in nucleosides induced by 2-bromopropane at the physiological condition was investigated. Similarly, incubation of calf-thymus DNA with the excess amount 2-BP at the physiological condition was also performed. In addition, the time and dose response relationship of depurination in calf-thymus DNA induced by 2-BP at the physiological condition was investigated. Those results suggest that the toxic effect of 2-BP could be both from the depurination of nucleosides and DNA adduct formation.
Introduction
The depurination of nucleic acids, the release of purine bases from nucleic acids by hydrolysis of the N-glycosidic bond ( Fig.  1) , gives rise to alterations of the cell genome. 1, 2 The apurinic sites resulting from depurination are quite stable, 3 and cells have evolved mechanisms to repair these lesions. 4 However, unrepaired apurinic sites have been shown to have two biological consequences: lethality 5, 6 and base substitution errors. 6 Depurination leaves the DNA phosphodiester backbone intact and leaves apurinic site. Apurinic sites are excellent candidates for becoming the causative lesions; they are mutagenic in vivo only after induction of SOS 6, 7, 8 system, and they induce G:C → T:A and A:T → T:A transversions characteristically as a result of preferential insertion of adenine residues opposite apurinic sites during DNA replication 9, 10 resulting in base substitution errors. More recently, it has been reported that in early preneoplastic mouse skin, apurinic sites formed by the PAH carcinogen dibenzo[a,l] pyrene (DB[a,l]) undergo error-prone repair to form tumor-intitiating H-ras mutations, 11 by inducing pre-replication repair that is error-prone and forms mismatched heteroduplexes leading to transforming mutations in H-ras gene at codon 61 (CAA to CTA). 12 It has been reported by the Hazardous Substances Data Bank (HSDB) 13 that 2-bromopropane (2-BP) is used as an intermediate in the synthesis of pharmaceuticals, dyes, and other organics. The extent of their uses and associated human exposures is unknown. 2-BP (CAS No. 75-26-3) has been used as a cleaning solvent in the electronics industry in order to replace chloroflu-orocarbons (CFCs) and 1,1,1-trichloroethane 14, 15, 16, 17 as their use and production became prohibited in developed countries since January 1 st 1996, following the international agreement for the protection of the ozone layer. 18 But in 1995, an outbreak of reproductive and hematopoietic disorders occurred in male and female workers exposed to a solvent containing 2-BP as a major ingredient in an electronics factory in South Korea, 14, 16, 19 which caused the Korean Ministry of Labor to establish the threshold limit value (TLV) for 2-BP in the workplace as 1 ppm. 20 Owing to the toxicity of 2-BP, there has been a growing tendency to use 1-bromopropane (1-BP) as an alternative cleaning solvent to 2-BP. However, 1-BP cause a depressing action on the central nervous system (CNS) 21 and is reported to cause irritation to the skin and eyes of mice. 22 But the details of 1-BP toxicity have not been studied well until recently. Presently, 1-BP is still used in the work place despite insufficient information regarding its toxicity. 23 We have reported that formation of N 7 -guanine adducts (N 7 -propyl guanine or N 7 -isopropyl guanine, respectively) in DNA by 1-BP or 2-BP would be one of the mechanisms for its toxicity. 24 However, we observed massive depurination of nucleosides such as 2',3'-dideoxyadenosine (ddA), 2'-deoxyadenosine (dA), 25 2',3'-dideoxyguanosine (ddG), 2'-deoxyguanosine (dG), 25 and calf thymus DNA when the nucleosides and calf thymus DNA were incubated with an excess amount of 2-BP at the physiological condition.
Methods and Materials
Chemicals and reagents. 1-Bromopropane (1-BP, 99%), 2-bromopropane (2-BP, 99%), 2'-deoxyadenosine (dA, 99∼100 %), 2'-deoxyguanosine hydrate (dG, 99%), adenosine (Ado, 99%), guanosine hydrate (Guo, 98%), calf-thymus DNA (deoxyribonucleic acid sodium salt, from calf thymus), 5-flurouracil (5-FU, 99%), 5-flurouridine(5-FUri, 99%), phosphate buffered saline (pH 7.4) and ammonium acetate (99.995+%) were purchased from Sigma Aldrich Co. (ST. Louis, MO). 2',3'-Dideoxyadenosine (ddA) and 2',3'-dideoxyguanosine (ddG) were obtained from Berry & Associates Inc. 9-Methyl adenine was prepared in our lab. HPLC grade acetonitrile and methanol was purchased from World Science, Korea.
Preliminary reactions. One mg of nucleoside (ddA, dA, adenine, ddG, dG and guanine) was dissolved in 1 mL phosphate buffered saline solution (PBS) in 5 mL vial. Ten µL (5 mg in 1 mL PBS) of 5-flurouridine (5-FUri) for adenine-based nucleosides and 20 µL (10 mg in 1 mL PBS) of 5-flurouracil (5-FU) for guanine-based nucleosides was added as an internal standard, respectively. It was then incubated with excess amount (512 equivalents) of 1-BP or 2-BP at the physiological condition for 48 h. Then it was analyzed by HPLC and further confirmed by LC-MS/MS. All the reactions were repeated for three times.
Time response reaction. One mg of nucleoside (ddA, dA, ddG and dG) was dissolved in 1 mL phosphate buffered saline solution (PBS) in 5 mL vial separately. Ten µL (5 mg in 1 mL PBS) of 5-flurouridine (5-FUri) for adenine-based nucleosides and 20 µL (10 mg in 1 mL PBS) of 5-flurouracil (5-FU) for guaninebased nucleosides was added as an internal standard, respectively. It was then incubated with excess amount (512 equivalent) of 2-BP at the physiological condition. About 10 µL of samples were withdrawn after time interval of 1 and 3 h, respectively, for dideoxy and deoxy nucleosides and then analyzed by HPLC until 100% depurination occurred. All the reactions were repeated for three times.
Dose response reaction. One mg of nucleoside (ddA, dA, ddG and dG) was dissolved in 1 mL phosphate buffered saline solution (PBS) in 5 mL vial separately. Ten µL (5 mg in 1 mL PBS) of 5-flurouridine (5-FUri) for adenine-based nucleosides and 20 µL (10 mg in 1 mL PBS) of 5-flurouracil (5-FU) for guaninebased nucleosides was added as an internal standard, respectively. It was then incubated with different amounts (0, 2, 4, 8, 16, 32, 64, 128, 256 and 512 equivalents) of 2-BP at the physiological condition for a time period at which 100% depurination occurred according to time response reaction, which was identified as 24 h. Again the samples were analyzed by HPLC and repeated for three times.
Reactions with calf-thymus DNA (ct-DNA). Two mg of ct-DNA was dissolved in 20 mL of PBS solution and 40 µL of 9-methyl adenine (0.5 mg in 1 mL PBS) was added as an internal standard and stirred to mix properly. One ml of the above prepared solution of ct-DNA was taken in 5 mL vial and incubated with 128 µL of 2-BP at the physiological condition for 48 h as a preliminary reaction. At the end of the reaction 300 µL of 1 M aqueous HCl was added and centrifuged for 10 min at 13,000 rpm. Then the supernatant was analyzed by LC-MS/MS under the condition mentioned below.
Time response reaction was performed with 128 µL of 2-BP at a time interval of 8 h for 0, 8, 16, 24, 32, 40 and 48 h. Again, at the end of the reaction 300 µL of 1 M aqueous HCl was added and centrifuged for 10 min at 13,000 rpm. Then the supernatant was analyzed by LC-MS/MS under the condition mentioned below.
Dose response reaction was performed with 2, 4, 8, 16, 32, 64 and 128 µL of 2-BP separately for 48 h. Again, at the end of the reaction 300 µL of 1 M aqueous HCl was added and centrifuged for 10 min at 13,000 rpm. Then the supernatant was analyzed by LC-MS/MS under the condition mentioned below.
Calculation for depurination ratio in nucleosides. Depurination ratio (DR%) was calculated on the basis of the decreased amount of the nucleosides in percentage by comparing the integration value of the nucleosides in HPLC using the formula below:
where 'Ao' is the initial amount of nucleoside; 'At' is the amount of nucleoside after time, t ; 'ISo' is the initial amount of internal standard and 'ISt' is the amount of nucleoside after time, t.
Calculation for depurination ratio in ct-DNA. Depurination ratio (DR) was calculated on the basis of the increased amount of adenine or guanine compared with the internal standard (IS) by comparing the integration value in EIC from LC-MS/MS using the formula below: Depurination ratio = Adenine IS Depurination ratio = Guanine IS Apparatus. HPLC analysis were performed using two Shimadzu LC-10AT pumps gradient-controlled HPLC system equipped with Shimadzu photo diode array detector (Model SPD-M10A) and dual channel UV detection at 280 nm. Analytes were eluted with a 4.6 × 250 mm, 5 µm Waters XTerra® C18 reverse phase analytical column using the following HPLC condition: Isocratically with 4% or 5% acetonitrile in water with 50 mM ammonium formate, pH 6.9, for 20 minutes at a flow rate of 1 mL/min and 10 µL injection volume for guanine-based or adenine-based nucleosides, respectively.
ESI LC/MS analyses were performed with a Finnigan LCQ Advantage® LC-MS/MS spectrometry utilizing Xcalibur® program. The samples were analyzed using 2.1 × 150 mm, 3.5 µm Waters XTerra® C18 reverse phase analytical column using the following LC condition: Isocratically with 3% acetonitrile in water with 50 mM ammonium formate, pH 6.9, for 20 minutes at a flow rate of 0.18 mL/min and 2 µL injection volume. The mass spectrometer was operated in the positive polarity mode with ESI source type. Capillary voltage was controlled at 10 V and 270 o C and Nitrogen gas was used as the sheath gas. Centrifugation was done using Hanil Micro-12 (made in Korea) with maximum capacity 1.5 mL × 12, maximum speed 13,000 rpm, maximum RCF 10,770 × g and power AC 110 V, 60 Hz.
Statistical analysis. All the reactions were performed at least three times (n ≥ 3). The mean value ± standard error (SE) was determined for each test. Student's t-test was used to compare statistical significance of data. The significant values at either P < 0.05(*) or P < 0.01(**) are represented by asterisks. Figure 2 shows the HPLC chromatograms under the chromatographic condition described in material and methods for the analysis of deadenylation of ddA induced by 1-BP or 2-BP.
Results

Analysis of deadenylation of ddA induced by 1-BP or 2-BP by HPLC.
In Figure 2 , chromatogram 1 indicates authentic adenine (Ade) at retention time of 6.20 min, and chromatogram 2 indicates the mixture of ddA and 5-fuorouridine (5-FUri) utilized as an internal standard at retention times of 16.51 min and 4.69 min, respectively. Adenine, ddA and 5-fuorouridine were well separated from the biological background under the described chromatographic condition. Chromatogram 3 indicates the mixture after incubation of ddA and excess amount (512 equivalent) of 1-BP for 48 h at the physiological condition, which informs almost no change in amount of ddA and no production of adenine at that condition. Chromatogram 4 indicates the mixture after incubation of ddA and excess amount (512 equivalent) of 2-BP for 48 h at the physiological condition, which indicates the peak of retention time at 16 .51 min which corresponds to ddA completely disappeared and a peak of retention time at 6.20 min corresponding to adenine newly appeared. The results indicated that complete deadenylation occurred when ddA was incubated with excess amount of 2-BP for 48 h.
Analysis of deadenylation of dA induced by 1-BP or 2-BP by HPLC 25 . Figure 3 shows the HPLC chromatograms under the chromatographic condition described in material and methods for the analysis of deadenylation of dA induced by 1-BP or 2-BP.
In Figure 3 , chromatogram 1 indicates authentic adenine at retention time of 6.20 min, and chromatogram 2 indicates the mixture of dA and 5-fuorouridine utilized as an internal standard at retention times of 11.40 min and 4.69 min, respectively. Adenine, dA and 5-fuorouridine were well separated from the biological background under the described chromatographic condition. Chromatogram 3 indicates the mixture after incubation of dA and excess amount (512 equivalent) of 1-BP for 48 h at the physiological condition, which informs almost no change in amount of dA and no production of adenine at that condition. Chromatogram 4 indicates the mixture after incubation of dA and excess amount (512 equivalent) of 2-BP for 48 h at the physiological condition, which indicates the peak of retention time Figure 4 shows the HPLC chromatograms under the chromatographic condition described in material and methods for the analysis of deadenylation of adenosine induced by 1-BP or 2-BP.
In Figure 4 , chromatogram 1 indicates authentic adenine at retention time of 6.20 min, and chromatogram 2 indicates the mixture of adenosine and 5-fuorouridine utilized as an internal standard at retention times of 11.34 min and 4.69 min, respectively. Adenine, adenosine and 5-fuorouridine were well separated from the biological background under the described chromatographic condition. Chromatogram 3 indicates the mixture after incubation of adenosine and excess amount (512 equivalent) of 1-BP for 48 h at the physiological condition, which informs almost no change in amount of adenosine and no production of adenine at that condition. Chromatogram 4 indicates the mixture after incubation of adenosine and excess amount (512 equivalent) of 2-BP for 48 h at the physiological condition, which also indicates almost no change in amount of adenosine and no production of adenine at that condition. The results indicated that no deadenylation occurred when adenosine was incubated with excess amount of 1-BP or 2-BP for 48 h. In Figures 2, 3 and 4, any change in amount of 5-fuorouridine during incubation of ddA, dA and adenosine with 1-BP or 2-BP was not observed, which indicates the concentration of 5-fuorouridine was consistently well maintained and 5-fuorouridine was not affected by 1-BP, 2-BP or nucleosides.
Analysis of deguanylation of ddG induced by 1-BP or 2-BP by HPLC. Figure 5 shows the HPLC chromatograms under the chromatographic condition described in material and methods for the analysis of deguanylation of ddG induced by 1-BP or 2-BP.
In Figure 5 , chromatogram 1 indicates authentic guanine (Gua) at retention time of 4.87 min, and chromatogram 2 indicates the mixture of ddG and 5-fuorouracil (5-FU) utilized as an internal standard at retention times of 12.83 min and 4.12 min, respectively. Guanine, ddG and 5-fuorouracil were well separated from the biological background under the described chromatographic condition. Chromatogram 3 indicates the mixture after incubation of ddG and excess amount (512 equivalent) of 1-BP for 48 h at the physiological condition, which informs almost no change in amount of ddG and no production of guanine at that condition. Chromatogram 4 indicates the mixture after incubation of ddG and excess amount (512 equivalent) of 2-BP for 48 h at the physiological condition, which indicates the peak of retention time at 12.83 min which corresponds to ddG completely disappeared and a peak of retention time at 4.87 min corresponding to guanine newly appeared. The results indicated that complete deguanylation occurred when ddG was incubated with an excess amount of 2-BP for 48 h. 25 . Figure 6 shows the HPLC chromatograms under the chromatographic condition described in material and methods for the analysis of deguanylation of dG induced by 1-BP or 2-BP. In Figure 6 , chromatogram 1 indicates authentic guanine at retention time of 4.82 min, and chromatogram 2 indicates the mixture of dG and 5-fuorouracil utilized as an internal standard at retention times of 8.38 min and 4.08 min, respectively. Guanine, dG and 5-fuorouracil were well separated from the biological background under the described chromatographic condition. Chromatogram 3 indicates the mixture after incubation of dG and excess amount (512 equivalent) of 1-BP for 48 h at the physiological condition, which informs almost no change in amount of dG and no production of guanine at that condition. Chromatogram 4 indicates the mixture after incubation of dG and excess amount (512 equivalent) of 2-BP for 48 h at the physiological condition, which indicates the peak of retention time at 8.38 min which corresponds to dG completely disappeared and a peak of retention time at 4.82 min corresponding to guanine newly appeared. The results indicated that complete deguanylation occurred when dG was incubated with an excess amount of 2-BP for 48 h.
Analysis of deguanylation of dG induced by 1-BP or 2-BP by HPLC
Analysis of deguanylation of guanosine induced by 1-BP or 2-BP by HPLC. Figure 7 shows the HPLC chromatograms under the chromatographic condition described in material and methods for the analysis of deguanylation of guanosine induced by 1-BP or 2-BP.
In Figure 7 , chromatogram 1 indicates authentic guanine at retention time of 4.76 min, and chromatogram 2 indicates the mixture of guanosine and 5-fuorouracil utilized as an internal standard at retention times of 6.70 min and 4.06 min, respectively. Guanine, guanosine and 5-fuorouracil were well separated from the biological background under the described chromatographic condition. Chromatogram 3 indicates the mixture after incubation of guanosine and excess amount (512 equivalent) of 1-BP for 48 h at the physiological condition, which informs almost no change in amount of guanosine and no production of guanine at that condition. Chromatogram 4 indicates the mixture after incubation of guanosine and an excess amount (512 equivalent) of 2-BP for 48 h at the physiological condition, which also indicates almost no change in amount of guanosine and only small amount of production of guanine at that condition. The results indicate that no deguanylation occurred when guanosine was incubated with excess amount of 1-BP or 2-BP for 48 h. In Figures 5, 6 and 7, any change in amount of 5-fuorouracil during incubation of ddG, dG and guanosine with 1-BP or 2-BP was not observed, which indicates the concentration of 5-fuorouracil was consistently well maintained and 5-fuorouracil was not affected by 1-BP, 2-BP or nucleosides. From the HPLC analysis, it was found that 100% depurination occurred in ddA, dA, ddG and dG by excess amount of 2-BP at the physiological condition for 48 hr. However, almost no depurination was observed in adenosine and guanosine by 2-BP. In addition, no depurination was also observed in nucleosides by 1-BP, which was summarized in Table 1 and 2 .
Analysis of time response depurination of ddA, dA, ddG and dG induced by 2-BP. Figure 8 shows time response curves of depurination rate of ddA, dA, ddG or dG induced by 2-BP according to time. Figure 8(a) indicates time response curve of deadenylation after incubation of ddA and 512 dose equivalent of 2-BP at the physiological condition at a time interval of 1 h. Deadenylation begin to occur at 5 h, and drastically increase until 9 h in time dependent manner. Complete deadenylation occurred at 10 h. Figure 8 (b) 25 indicates time response curve of deadenylation after incubation of dA and 512 dose equivalent of 2-BP at the physiological condition at a time interval of 3 h. Deadenylation begin to occur at 6 h, and drastically increase until 18 h in time dependent manner. Complete deadenylation occurred at 21 h. Comparing deadenylation rates of ddA and dA, deadenylation rate of ddA was much faster than that of dA. indicates time response curve of deguanylation after incubation of dG and 512 dose equivalent of 2-BP at the physiological condition at a time interval of 3 h. Deguanylation begin to occur at 3 h, and drastically increase until 15 h in time dependent manner. Complete deguanylation occurred at 18 h. Comparing deguanylation rates of ddG and dG, deguanylation rate of ddG was much faster than that of dG. Regarding depurination rates of ddA, dA, ddG and dG, the order of depurination rate was observed as ddG > ddA > dG > dA. Analysis of dose response depurination of ddA, dA, ddG and dG induced by 2-BP. Figure 9 shows dose response curves of depurination rate of ddA, ddG, dA or dG induced by 2-BP according to dose. Figure 9 (a) indicates dose response curve of deadenylation after incubation of ddA and different dose equivalent of 2-BP at the physiological condition for 24 h. Deadenylation begin to occur at 4 dose equivalent of 2-BP, and drastically increase until 16 dose equivalent of 2-BP in dose dependent manner. Complete deadenylation occurred at 32 dose equivalent of 2-BP. Figure 9 (b) 25 indicates dose response curve of deadenylation after incubation of dA and different dose equivalent of 2-BP at the physiological condition for 24 h. Deadenylation begin to occur at 2 dose equivalent of 2-BP, and drastically increase until 16 dose equivalent of 2-BP in dose dependent manner.
Complete deadenylation occurred at 32 dose equivalent of 2-BP. Figure 9 (c) indicates dose response curve of deguanylation after incubation of ddG and different dose equivalent of 2-BP at the physiological condition for 24 h. Deguanylation begin to occur at 8 dose equivalent of 2-BP, and drastically increase until 128 dose equivalent of 2-BP in a dose dependent manner. Complete deguanylation occurred at 256 dose equivalent of 2-BP. Figure 9 (d) 25 indicates dose response curve of deguanylation after incubation of dG and different dose equivalent of 2-BP at the physiological condition for 24 h. Deguanylation begin to occur at 2 dose equivalent of 2-BP, and drastically increase until 16 dose equivalent of 2-BP in a dose dependent manner. Complete deguanylation was occurred at 32 dose equivalent of 2-BP.
Analysis of time response depurination of calf thymus DNA induced by 2-BP. Figure 10 shows time response curves of depurination rate of calf thymus DNA induced by 2-BP according to time. The formation of adenine and guanine from calf thymus DNA by treatment with 128 µL of 2-BP was observed in time response manner.
Analysis of dose response depurination of calf thymus DNA induced by 2-BP. Figure 11 shows dose response curves of depurination rate of calf thymus DNA induced by 2-BP according to dose. The formation of adenine and guanine from calf thymus DNA by treatment with 2-BP was observed in dose response manner for 48 h. 
Discussion
Depurination ratio (%) in nucleosides was calculated on the basis of the decreased amount of nucleosides in percentage by comparing the integration value of the nucleosides in HPLC using the formula mentioned in materials and methods. The depurinated products of nucleosides (ddA, dA, ddG and dG) are adenine and guanine, respectively. Since the solubility of guanine is relatively low at physiological condition, the guanine formed after depurination precipitates in pH 7.4 buffer solution, which decreases the accuracy of depurination ratio if we apply the increasing amount of depurinated product (adenine or guanine) for the determination of depurination ratio. Therefore, we applied the decreasing amounts of nucleosides for the determination of depurination ratio. Meanwhile, depurination ratio in calf thymus DNA was calculated on the basis of the increased amount of adenine or guanine by comparing the integration value between increased adenine or guanine and internal standard in EIC from LC-MS/MS using the formula mentioned in materials and methods. Since guanine is soluble in acidic condition, 1 M aqueous HCl was added to dissolve the precipitated guanine before analysis. In Figures 2, 3 and 4, chromatogram 1 shows the peak of authentic adenine as references, chromatogram 2 shows that of adenine based-nucleosides, ddA, dA or adenosine, along with the peak of internal standard, chromatogram 3 and 4 show the peaks of products formed after incubation of ddA, dA or adenosine with 1-BP or 2-BP for 48 h, respectively. In Figures 5, 6 and 7, chromatogram 1 shows the peak of authentic guanine as references, chromatogram 2 shows that of guanine based-nucleosides, ddG, dG or guanosine, along with the peak of internal standard, chromatogram 3 and 4 show the peaks of products formed after incubation of ddG, dG or guanosine with 1-BP or 2-BP for 48 h, respectively. It is evident that the peaks of ddA, dA, ddG or dG completely disappeared and the peaks of adenine or guanine have appeared after incubation with 2-BP for 48 h (chromatogram 4 in Figures 2, 3, 5 and 6 ). However, almost no change of chromatogram was observed after incubation of nucleosides with 1-BP for 48 h (chromatogram 3 in Figures 2, 3, 4 , 5, 6 and 7) or incubation of adenosine and guanosine with 2-BP for 48 h (chromatogram 4 in Figures 4  and 7) . These results indicated that 100% depurination occurred in ddA, dA, ddG and dG by 2-BP, but practically no depurination occurred by 1-BP (Tables 1 and 2 ). In addition, only small amount of depurination occurred by incubation of adenosine or guanosine with 2-BP.
Time and dose response reaction with ddA, dA, ddG and dG by 2-BP indicated that depurination increased in time and dose dependent manner (Figures 8 and 9 ). In time response reaction, depurination increased in time dependent manner, and complete depurination was observed after 10 h in ddA, 6 h in ddG and 21 h in both dA and dG by 2-BP (Figure 8 order of depurination rates was observed as ddG > ddA > dG > dA, which is in accordance with the result reported by Kochetkov. 26 He reported that depurination was highest with dideoxy followed by deoxy and then ribose nucleosides which follow that 2-deoxyribosyl derivative are hydrolyzed 100∼1000 times faster than the corresponding ribosyl derivatives. Depurination was also found to be greater in case of guanine based nucleosides than adenine based nucleosides which also follow the order of reactivity given by Kochetkov: deoxyguanosine > deoxyadenosine >> guanosine > adenosine > dexoycytidine > deoxythymidine >> cytidine = uridine [26] [27] [28] [29] [30] . In dose response reaction, depurination increased in dose dependent manner, and complete depurination was observed with both 32 dose equivalents for 24 h incubation in ddA, dA and dG, and 128 dose equivalents for 24 h incubation in ddG (Figure 9 ).
Time and dose response reaction with calf thymus DNA by 2-BP indicated that depurination increased in time and dose dependent manner (Figures 10 and 11 ). In case of the calf thymus DNA, the rate of depurination of dA is faster than dG. This may be explained by that guanine is bound to cytosine with three H-bonds whereas adenine is bound to thymine with two H-bonds in double stranded DNA, which makes adenine easy to detach from the chain.
Conclusion
We observed depurination of ddA, dA, ddG and dG induced by 2-BP as a probable mechanism of toxicity. In terms of rate of depurination, dideoxy showed the highest reactivity followed by deoxy and then ribose nucleosides. Although the exact mechanism of depurination is not known, it shows that hydroxyl group in the sugar moiety of the nucleosides plays an important role in rate of depurination. It was also found that 2-BP showed faster rate of depurination than 1-BP, which indicated that secondary alkyl halide displayed greater reactivity than primary alkyl halide in the rate of depurination. Since the mechanism of depurination is unknown at the present time, a study to elucidate mechanism of depurination is in progress.
